Laboratory Equipment and Instruments

Polyplus-transfection Launches Residual Test for Transfection Reagents

August 03, 2020

The company has launched a residual GMP-compliant test and dual sourcing opportunity designed to increase compliance and reduce risks for ATMP manufacture.

Rigenerand Develops 3D Bioreactor for Extracellular Vesicle Exosomes Production

July 31, 2020

The company has begun development of a 3D bioreactor for the cGMP production of extracellular vesicle exosomes.

Stevanato Group, Colanar Partner Up on Fill/Finish Capabilities

July 23, 2020

Stevanato Group and Colanar have signed an agreement for lab scale fill/finish capabilities to study container closure systems at Stevanato Group’s US TEC in Boston, MA.

A Novel Method for Host Cell Protein Analysis

July 13, 2020

This method is expected to help bring gene therapies to market faster, safer, and cheaper.

LabVantage Adds SDMS to LIMS Platform

July 09, 2020

The new SDMS automatically gathers and protects all instrument and other laboratory data as it is generated for enhanced lab management, quality, and security.

Pharmaceutical Technology Europe

Analytical Assays Determine Biosimilar Product Quality

July 01, 2020

Appropriate analytical assays are needed to determine and ensure that biosimilar critical quality parameters are on track.

Shimadzu’s New LCMS-8060NX Mass Spectrometer Offers Enhanced Performance

June 29, 2020

Pharmaceutical Technology's In the Lab eNewsletter

Enhanced sensitivity and ultra-high detection speed provide improved robustness and operability.

Pall’s 24-Well Filter Plate Performs Cell Clarification and Sterilization

June 29, 2020

Pharmaceutical Technology's In the Lab eNewsletter

Pall has introduced a 24-well filter plate that can perform cell clarification and sterilization in one step.

Avacta Provides Updates on COVID-19 Antigen Diagnostic Test Development

June 29, 2020

Pharmaceutical Technology's In the Lab eNewsletter

The company has provided updates on its COVID-19 tests under development with Adeptrix and Cytiva, respectively.

PPD to Expand its Laboratory Portfolio for COVID-19 Vaccines and Therapies

June 25, 2020

The company has expanded its laboratory test portfolio with five new molecular, serology, and functional assays for COVID-19 vaccine and therapy development programs.